Healthcare and IT companies still dominate the dealflow as we close the first quarter of 2014, during which Global University Venturing recorded 95 deals and 21 new funds linked to supporting university innovation.
In a trend which shows no signs of slowing down any time soon, healthcare deals still account for the lion’s share of university spin-out deals. Healthcare deals represent around a third of all deals reported in the quarter, and also shows encouraging signs in finding that early-stage financing necessary to effective develop technology in this sector.
Evidence of this comes in the form of Juno Therapeutics. Formed in December last year, the collaboration between St Jude Children’s Research Centre, the…
